XML 95 R41.htm IDEA: XBRL DOCUMENT
v3.25.1

FINANCIAL ASSETS AND LIABILITIES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Financial Assets And Liabilities |
Schedule of financial assets at amortized cost |
Schedule of financial assets at amortized cost |  |  |  |
|  | 12.31.2024 |  | 12.31.2023
Current |  |  |  |
Term deposit |  | 80 |  | 101
Notes receivable |  | - |  | 4
Total current |  | 80 |  | 105
Schedule of financial assets at fair value through profit and loss |
Schedule of financial assets at fair value through profit and loss |  |  |  |
|  | 12.31.2024 |  | 12.31.2023
Non-current |  |  |  |
Shares |  | 27 |  | 35
Total non-current |  | 27 |  | 35
Current |  |  |  |
Government securities |  | 692 |  | 389
Corporate bonds |  | 110 |  | 79
Shares |  | 37 |  | 88
Mutual funds |  | 11 |  | 3
Total current |  | 850 |  | 559
Schedule of trade and other receivables |
Schedule of trade and other receivables |  |  |  |  |
| Note |  | 12.31.2024 |  | 12.31.2023
Non-Current |  |  |  |  |
Related parties | 16 |  | 4 |  | 11
Advances to suppliers |  |  | 43 |  | -
Prepaid expenses |  |  | 5 |  | -
Tax credits |  |  | 8 |  | 1
Receivables for sale of associates |  |  | - |  | 1
Receivables for sale of assets |  |  | 10 |  | -
Contractual indemnity receivable |  |  | 2 |  | 4
Expenses to be recovered |  |  | 3 |  | -
Other |  |  | - |  | 1
Other receivables |  |  | 75 |  | 18
Total non-current |  |  | 75 |  | 18
| Note |  | 12.31.2024 |  | 12.31.2023
Current |  |  |  |  |
Receivables |  |  | 172 |  | 105
CAMMESA |  |  | 107 |  | 100
Related parties | 16 |  | 10 |  | 5
Impairment of financial assets |  |  | (1) |  | (1)
Trade receivables, net |  |  | 288 |  | 209
Current |  |  |  |  |
Related parties | 16 |  | 11 |  | 7
Tax credits |  |  | 8 |  | 10
Receivables for complementary activities |  |  | 9 |  | 1
Prepaid expenses |  |  | 3 |  | 5
Guarantee deposits |  |  | 130 |  | 19
Expenses to be recovered |  |  | 8 |  | 6
Insurance to be recovered |  |  | 1 |  | 4
Receivables for sale of associates |  |  | - |  | 1
Receivables for sale of assets |  |  | 6 |  | -
GasAr Plan |  |  | 7 |  | 11
Contractual indemnity receivable |  |  | 2 |  | 2
Receivable for maintenance contract |  |  | 1 |  | -
Advances to employees |  |  | - |  | 10
Other |  |  | 14 |  | 11
Other receivables, net |  |  | 200 |  | 87
Total current |  |  | 488 |  | 296
Schedule of allowance for the impairment of trade receivables |
Schedule of allowance for the impairment of trade receivables |  |  |  |  |  |  |
|  |  | 12.31.2024 |  | 12.31.2023 |  | 12.31.2022
At the beginning of the year |  |  | 1 |  | 6 |  | 9
Impairment |  |  | 55 |  | 1 |  | 1
Write off for utilization |  |  | (54) |  | - |  | (1)
Reversal of unused amounts |  |  | - |  | (1) |  | -
Foreign currency exchange difference |  |  | (1) |  | (5) |  | (3)
At the end of the year |  |  | 1 |  | 1 |  | 6
Schedule of cash and cash equivalents |
Schedule of cash and cash equivalents |  |  |  |
|  | 12.31.2024 |  | 12.31.2023
Cash |  | 1 |  | -
Banks |  | 73 |  | 31
Term deposit |  | 46 |  | -
Mutual funds |  | 618 |  | 140
Total |  | 738 |  | 171
Schedule of borrowings |
Schedule of borrowings |  |  |  |  |
|  |  | 12.31.2024 |  | 12.31.2023
Non-Current |  |  |  |  |
Financial borrowings |  |  | 32 |  | -
Corporate bonds |  |  | 1,341 |  | 1,224
Total non-current |  |  | 1,373 |  | 1,224
Current |  |  |  |  |
Bank overdrafts |  |  | - |  | 31
Financial borrowings |  |  | 122 |  | 67
Corporate bonds |  |  | 584 |  | 126
Total current |  |  | 706 |  | 224
Total |  |  | 2,079 |  | 1,448
Schedule of changes in borrowings |
Schedule of changes in borrowings |  |  |  |  |  |  |
|  |  | 12.31.2024 |  | 12.31.2023 |  | 12.31.2022
Borrowings at the beginning of the year |  |  | 1,448 |  | 1,613 |  | 1,438
Proceeds from borrowings |  |  | 1,174 |  | 424 |  | 308
Payment of borrowings |  |  | (236) |  | (191) |  | (143)
Accrued interest |  |  | 145 |  | 304 |  | 172
Payment of interests |  |  | (145) |  | (280) |  | (162)
Repurchase and redemption of CB |  |  | (313) |  | (6) |  | (28)
Result from repurchase and exchange of CB |  |  | 10 |  | (1) |  | 8
Increases for incorporation |  |  | - |  | - |  | 89
Foreign currency exchange difference |  |  | (12) |  | (356) |  | (80)
Decrease for sale of subsidiaries |  |  | - |  | (80) |  | -
Borrowing costs capitalized in property, plant and equipment |  |  | 8 |  | 21 |  | 11
Borrowings at the end of the year |  |  | 2,079 |  | 1,448 |  | 1,613
Schedule of borrowings composition |
Schedule of borrowings composition |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Type of instrument |  | Company |  | Currency |  | Residual value |  |  | Interest |  | Rate |  | Expiration |  | Book value as of 12.31.2024
Corporate bonds (1)(2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class 19 CB |  | PAMPA |  | $ |  | 17,131 |  |  | Variable |  | Badlar - 1% |  | Feb-25 |  | 17
Class 18 CB |  | PAMPA |  | US$ |  | 68 |  |  | Fixed |  | 5.00% |  | Sep-25 |  | 69
Class 16 CB |  | PAMPA |  | US$ |  | 56 |  |  | Fixed |  | 4.99% |  | Nov-25 |  | 56
Class 20 CB |  | PAMPA |  | US$ |  | 54 |  |  | Fixed |  | 6.00% |  | Mar-26 |  | 54
Class 9 CB |  | PAMPA |  | US$ |  | 120 |  |  | Fixed |  | 9.50% |  | Dec-26 |  | 123
Class 1 CB |  | PAMPA |  | US$ |  | 353 |  |  | Fixed |  | 7.50% |  | Jan-27 |  | 363
Class 13 CB |  | PAMPA |  | US$ |  | 98 |  |  | Fixed |  | 0.00% |  | Dec-27 |  | 96
Class 22 CB |  | PAMPA |  | US$ |  | 84 |  |  | Fixed |  | 5.75% |  | Oct-28 |  | 85
Class 3 CB |  | PAMPA |  | US$ |  | 293 |  |  | Fixed |  | 9.13% |  | Apr-29 |  | 294
Class 21 CB |  | PAMPA |  | US$ |  | 410 |  |  | Fixed |  | 7.95% |  | Sep -31 |  | 410
Class 23 CB |  | PAMPA |  | US$ |  | 360 |  |  | Fixed |  | 7.88% |  | Dec-34 |  | 358
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,925
Financial loans (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | US$ |  | 35 |  |  | Fixed |  | 3.00% |  | Mar-25 |  | 36
|  | PAMPA |  | US$ |  | 40 |  |  | Fixed |  | 4.25% |  | Apr-25 |  | 40
|  | PAMPA |  | US$ |  | 15 |  |  | Fixed |  | 5.40% |  | Mar-26 |  | 15
|  | PAMPA |  | US$ |  | 25 |  |  | Fixed |  | 3.00% |  | May-26 |  | 26
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 117
Other financial loans (4) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | US$ |  | 283 |  |  | Variable |  | SOFR + 0% |  | Aug-25 |  | 20
|  | PAMPA |  | US$ |  | 3 |  |  | Fixed |  | Between 9.50% and 10.25% |  | Between Feb-25 and Sep-25 |  | 3
|  | GASA |  | U$S |  | 14,937 |  |  | Fixed |  | 3.25% |  | May-25 |  | 14
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 37
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,079
| (1) | Net of repurchases for a face value of US$ 76.2 million for Class 9 CB and US$ 7.5 million for Class 3 CB.
| (2) | During the current year, on February 5, 2024 and June 27, 2024, the Company redeemed all its Class 17 and Class 15 CB for a total amount of $ 5,980 million and $ 18,264 million, respectively. Additionally, the Company paid at maturity the first redemption of Class 9 CB for a US$ 59 million amount net of repurchases. As of the date of issuance of these Consolidated Financial Statements, US$ 47 million FV of the Class 20 CB and $17,131 million at maturity of Class 19 CB, were canceled.
| (3) | During the fiscal year ended December 31, 2024, the Company repaid: (i) short-term bank debt with local financial institutions, net of cancellations, for $ 25,968 million; (ii) the last two principal installments of the FINNVERA Credit Facility for US$ 8 million; and (iii) net import financing for the equivalent of US$ 16 million. In addition, it borrowed US$ 130 million net from local banks. Post-closing, the Company borrowed US$ 31 million net bank debt.
| (4) | During the fiscal year ended December 31, 2024, the Company received disbursements in the amount of US$ 223 million under the credit facilities taken out with BNP Paribas S.A. in 2020.
Type of instrument |  | Company |  | Currency |  | Residual value |  |  | Interest |  | Rate |  | Expiration |  | Book value as of 12.31.2023
Corporate bonds (1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class 17 CB |  | PAMPA |  | $ |  | 5,980 |  |  | Fixed |  | Badlar + 2% |  | May-24 |  | 9
Class 15 CB |  | PAMPA |  | $ |  | 18,264 |  |  | Variable |  | Badlar + 0% |  | Jul-24 |  | 29
Class 18 CB |  | PAMPA |  | US$ |  | 72 |  |  | Fixed |  | 5.00% |  | Sep-25 |  | 73
Class 16 CB |  | PAMPA |  | US$ |  | 56 |  |  | Fixed |  | 4.99% |  | Nov-25 |  | 56
Class 9 CB |  | PAMPA |  | US$ |  | 179 |  |  | Fixed |  | 9.50% |  | Dec-26 |  | 184
Class 1 CB |  | PAMPA |  | US$ |  | 597 |  |  | Fixed |  | 7.50% |  | Jan-27 |  | 611
Class 13 CB |  | PAMPA |  | US$ |  | 98 |  |  | Fixed |  | 0.00% |  | Dec-27 |  | 96
Class 3 CB |  | PAMPA |  | US$ |  | 293 |  |  | Fixed |  | 9.13% |  | Apr-29 |  | 292
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,350
Financial loans (2)(3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | US$ |  | 8 |  |  | Variable |  | SOFR 6M + 4.21% |  | Nov-24 |  | 8
|  | PAMPA |  | $ |  | 3,000 |  |  | Variable |  | Between 80% and 110% |  | Between Apr-24 and Jun-24 |  | 5
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 13
Other financial loans (4) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | US$ |  | 22 |  |  | Variable |  | SOFR + 0.35% |  | Jul-24 |  | 23
|  | PAMPA |  | US$ |  | 12 |  |  | Variable |  | SOFR + 0% |  | Aug-24 |  | 12
|  | PAMPA |  | US$ |  | 14 |  |  | Fixed |  | Between 13% and 16% |  | Between Jan-24 and Jun-24 |  | 14
|  | PAMPA |  | CNY |  | 37 |  |  | Fixed |  | Between 12% and 12.50% |  | Between Mar-24 and Nov-24 |  | 5
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 54
Bank overdrafts (2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | PAMPA |  | $ |  | 23,140 |  |  | Fixed |  | Between79.00% and 81.00% |  | Between Jan-24 and Apr-24 |  | 31
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 31
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,448
| (1) | Net of repurchases for a face value of US$ 113.7 million for 2026 CB, US$ 153.0 million of 2027 CB, and US$ 7.5 million for 2029 CB.
| (2) | During the fiscal year ended December 31, 2023, the Company took out short-term bank loans with local financial institutions, net of cancellations, for $ 16,535 million and import financing for CNY 37 million. Additionally, it took out import financing, net, for US$ 6.2 million.
| (3) | Regarding the FINNVERA credit facility and due to the discontinuation of the Libor benchmark interest rate as from July 2023, on September 5, 2023, Pampa and CACIB (Credit Agricole Corporate & Investment Bank) entered into an amendment to the credit facility replacing the Libor rate with the Term SOFR rate for debt services after November 2023. In this same line, the interest rate hedge agreement associated with the credit facility was also amended.
| (4) | During the fiscal year ended December 31, 2023, the Company received disbursements in the amount of US$ 2.0 million under the credit facilities taken out with BNP Paribas S.A. in 2020.
Schedule of trade and other payables |
Schedule of trade and other payables |  |  |  |  |
| Note |  | 12.31.2024 |  | 12.31.2023
Non-Current |  |  |  |  |
Compensation agreements |  |  | 71 |  | 28
Finance leases liability |  |  | 11 |  | 14
Contractual penalty debt |  |  | 2 |  | 4
Other payables |  |  | 84 |  | 46
Total non-current |  |  | 84 |  | 46
Current |  |  |  |  |
Suppliers |  |  | 206 |  | 186
Customer advances |  |  | 14 |  | 9
Related parties | 16 |  | 13 |  | 15
Trade payables |  |  | 233 |  | 210
Compensation agreements |  |  | 12 |  | 11
Liability for acquisition of companies |  |  | - |  | 8
Finance leases liability |  |  | 4 |  | 4
Contractual penalty debt |  |  | 2 |  | 2
Various creditors |  |  | 2 |  | 3
Other payables |  |  | 20 |  | 28
Total current |  |  | 253 |  | 238
Schedule of financial instruments |
Schedule of financial instruments |  |  |  |  |  |  |  |  |  |
As of December 31, 2024 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non financial assets/liabilities |  | Total
Assets |  |  |  |  |  |  |  |  |  |
Trade and other receivables |  | 496 |  | - |  | 496 |  | 67 |  | 563
Financial assets at amortized cost |  |  |  |  |  |  |  |  |  |
Term deposit |  | 80 |  | - |  | 80 |  | - |  | 80
Financial assets at fair value through profit and loss |  |  |  |  |  |  |  |  |  |
Government securities |  | - |  | 692 |  | 692 |  | - |  | 692
Corporate bonds |  | - |  | 110 |  | 110 |  | - |  | 110
Shares |  | - |  | 64 |  | 64 |  | - |  | 64
Mutual funds |  | - |  | 11 |  | 11 |  | - |  | 11
Derivative financial instruments |  | - |  | 1 |  | 1 |  | - |  | 1
Cash and cash equivalents |  | 120 |  | 618 |  | 738 |  | - |  | 738
Total |  | 696 |  | 1,496 |  | 2,192 |  | 67 |  | 2,259
Liabilities |  |  |  |  |  |  |  |  |  |
Trade and other payables |  | 323 |  | - |  | 323 |  | 14 |  | 337
Borrowings |  | 2,079 |  | - |  | 2,079 |  | - |  | 2,079
Total |  | 2,402 |  | - |  | 2,402 |  | 14 |  | 2,416
As of December 31, 2023 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non financial assets/liabilities |  | Total
Assets |  |  |  |  |  |  |  |  |  |
Trade and other receivables |  | 279 |  | 7 |  | 286 |  | 28 |  | 314
Financial assets at amortized cost |  |  |  |  |  |  |  |  |  |
Term deposit |  | 101 |  | - |  | 101 |  | - |  | 101
Notes receivable |  | 4 |  | - |  | 4 |  | - |  | 4
Financial assets at fair value through profit and loss |  |  |  |  |  |  |  |  |  |
Government securities |  | - |  | 389 |  | 389 |  | - |  | 389
Corporate bonds |  | - |  | 79 |  | 79 |  | - |  | 79
Shares |  | - |  | 123 |  | 123 |  | - |  | 123
Mutual funds |  | - |  | 3 |  | 3 |  | - |  | 3
Cash and cash equivalents |  | 31 |  | 140 |  | 171 |  | - |  | 171
Total |  | 415 |  | 741 |  | 1,156 |  | 28 |  | 1,184
Liabilities |  |  |  |  |  |  |  |  |  |
Trade and other payables |  | 275 |  | - |  | 275 |  | 9 |  | 284
Borrowings |  | 1,448 |  | - |  | 1,448 |  | - |  | 1,448
Total |  | 1,723 |  | - |  | 1,723 |  | 9 |  | 1,732
Schedule of income, expenses, gains and losses from financial instruments |
Schedule of income, expenses, gains and losses from financial instruments |  |  |  |  |  |  |  |  |  |
As of December 31, 2024 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non Financial assets/ liabilities |  | Total
Interest income |  | 32 |  | - |  | 32 |  | - |  | 32
Interest expenses |  | (146) |  | - |  | (146) |  | (34) |  | (180)
Foreign currency exchange difference, net |  | (23) |  | (30) |  | (53) |  | 42 |  | (11)
Changes in the fair value of financial instruments |  | (11) |  | 250 |  | 239 |  | - |  | 239
Result from present value measurement |  | (2) |  | - |  | (2) |  | (5) |  | (7)
Other financial results |  | (15) |  | - |  | (15) |  | - |  | (15)
Total |  | (165) |  | 220 |  | 55 |  | 3 |  | 58
As of December 31, 2023 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non Financial assets/ liabilities |  | Total
Interest income |  | 5 |  | - |  | 5 |  | - |  | 5
Interest expenses |  | (307) |  | - |  | (307) |  | (49) |  | (356)
Foreign currency exchange difference, net |  | (1,035) |  | (560) |  | (1,595) |  | 1,718 |  | 123
Changes in the fair value of financial instruments |  | - |  | 444 |  | 444 |  | - |  | 444
Result from present value measurement |  | (1) |  | - |  | (1) |  | (9) |  | (10)
Other financial results |  | (7) |  | - |  | (7) |  | - |  | (7)
Total |  | (1,345) |  | (116) |  | (1,461) |  | 1,660 |  | 199
As of December 31, 2022 |  | Financial assets/liabilities at amortized cost |  | Financial assets/liabilities at fair value through profit and loss |  | Subtotal financial assets/liabilities |  | Non Financial assets/ liabilities |  | Total
Interest income |  | 5 |  | - |  | 5 |  | - |  | 5
Interest expenses |  | (175) |  | - |  | (175) |  | (41) |  | (216)
Foreign currency exchange difference, net |  | 16 |  | (85) |  | (69) |  | 149 |  | 80
Changes in the fair value of financial instruments |  | - |  | 110 |  | 110 |  | - |  | 110
Result from present value measurement |  | (1) |  | - |  | (1) |  | (13) |  | (14)
Other financial results |  | (15) |  | - |  | (15) |  | - |  | (15)
Total |  | (170) |  | 25 |  | (145) |  | 95 |  | (50)
Schedule of fair value of financial instruments |
Schedule of fair value of financial instruments |  |  |  |  |  |  |  |
As of December 31, 2024 |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |
Financial assets at fair value through profit and loss |  |  |  |  |  |  |  |
Government securities |  | 692 |  | - |  | - |  | 692
Corporate bonds |  | 110 |  | - |  | - |  | 110
Mutual funds |  | 11 |  | - |  | - |  | 11
Shares |  | 37 |  | - |  | 27 |  | 64
Cash and cash equivalents |  |  |  |  |  |  |  |
Mutual funds |  | 618 |  | - |  | - |  | 618
Derivative financial instruments |  | - |  | 1 |  | - |  | 1
Total assets |  | 1,468 |  | 1 |  | 27 |  | 1,496
As of December 31, 2023 |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |
Financial assets at fair value through profit and loss |  |  |  |  |  |  |  |
Government securities |  | 389 |  | - |  | - |  | 389
Corporate bonds |  | 79 |  | - |  | - |  | 79
Mutual funds |  | 3 |  | - |  | - |  | 3
Shares |  | 88 |  | - |  | 35 |  | 123
Cash and cash equivalents |  |  |  |  |  |  |  |
Mutual funds |  | 140 |  | - |  | - |  | 140
Other receivables |  |  |  |  |  |  |  |
Guarantee deposits on derivative financial instruments |  | 7 |  | - |  | - |  | 7
Total assets |  | 706 |  | - |  | 35 |  | 741

X
- References No definition available. + Details
Name: | pam_DisclosureFinancialAssetsAndLiabilitiesAbstract
Namespace Prefix: | pam_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfAllowanceForImpairmentOfTradeReceivablesTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfBorrowingsCompositionTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfBorrowingsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfChangesInBorrowingsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfFairValueOfFinancialInstrumentsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfFinancialAssetsAtAmortizedCostTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfFinancialAssetsAtFairValueThroughProfitAndLossTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfFinancialInstrumentsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfIncomeExpensesGainsAndLossesFromFinancialInstrumentsTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfTradeAndOtherPayablesTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pam_DisclosureOfTradeAndOtherReceivablesTableTextBlock
Namespace Prefix: | pam_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration